Polyarteritis nodosa natural history, complications and prognosis
Polyarteritis nodosa Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Polyarteritis nodosa natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Polyarteritis nodosa natural history, complications and prognosis |
FDA on Polyarteritis nodosa natural history, complications and prognosis |
CDC on Polyarteritis nodosa natural history, complications and prognosis |
Polyarteritis nodosa natural history, complications and prognosis in the news |
Blogs on Polyarteritis nodosa natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Haritha Machavarapu, M.B.B.S.
Overview
Natural History
- Untreated, the disease is fatal in most cases.
- The most serious associated conditions generally involve the kidneys and gastrointestinal tract.
- Without treatment, the outlook is poor.
Complications
- Complications include the following:
Prognosis
- Therapy results in remissions or cures in 90% of cases.
- Current treatments using steroids and other drugs that suppress the immune system (such as cyclophosphamide) can improve symptoms and the chance of long-term survival.
- Guillevin and coworkers have described five prognostic factors that predict high probability of mortality and are considered indications for another immunosuppressive drug in addition to prednisone.
- Proteinuria >1g/day
- Azotemia
- Cardiomyopathy
- Gastrointestinal involvement
- Central nervous system disease With none of these factors, 5-year mortality is 12%. With 2 or more 5-year mortality is 46%[1]
References
- ↑ Kelley's Textbook of Rheumatology,8th edition